Does NIRSEVIMAB Cause Respiratory syncytial virus infection? 38 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Respiratory syncytial virus infection have been filed in association with NIRSEVIMAB (BEYFORTUS). This represents 15.4% of all adverse event reports for NIRSEVIMAB.
38
Reports of Respiratory syncytial virus infection with NIRSEVIMAB
15.4%
of all NIRSEVIMAB reports
0
Deaths
38
Hospitalizations
How Dangerous Is Respiratory syncytial virus infection From NIRSEVIMAB?
Of the 38 reports, 38 (100.0%) required hospitalization, and 2 (5.3%) were considered life-threatening.
Is Respiratory syncytial virus infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIRSEVIMAB. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does NIRSEVIMAB Cause?
Respiratory syncytial virus bronchiolitis (87)
Drug ineffective (65)
Cough (19)
Pyrexia (15)
Apnoea (14)
Bronchiolitis (14)
Wheezing (13)
Incorrect dose administered (12)
Syringe issue (11)
Enteral nutrition (9)
What Other Drugs Cause Respiratory syncytial virus infection?
PALIVIZUMAB (1,692)
LENALIDOMIDE (355)
DUPILUMAB (261)
CYCLOPHOSPHAMIDE (201)
ADALIMUMAB (186)
PREDNISONE (186)
METHOTREXATE (182)
POMALIDOMIDE (181)
HUMAN IMMUNOGLOBULIN G (174)
TACROLIMUS (163)
Which NIRSEVIMAB Alternatives Have Lower Respiratory syncytial virus infection Risk?
NIRSEVIMAB vs NIRSEVIMAB-ALIP
NIRSEVIMAB vs NITAZOXANIDE
NIRSEVIMAB vs NITISINONE
NIRSEVIMAB vs NITRAZEPAM
NIRSEVIMAB vs NITRENDIPINE